Z. Xi

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.

S. M. Park, M. N. Duy, Le Tuan Linh, 2019, Lancet.

68Ga-labeled ODAP-Urea-based PSMA agents in prostate cancer: first-in-human imaging of an optimized agent

M. Pomper, Jinming Zhang, Xiaojun Zhang, 2021, European Journal of Nuclear Medicine and Molecular Imaging.

S-acylthioalkyl ester (SATE)-based prodrugs of deoxyribose cyclic dinucleotides (dCDNs) as the STING agonist for antitumor immunotherapy.

J. Quan, Yuchen Yang, Zhenghua Wang, 2022, European journal of medicinal chemistry.

(S)-3-(Carboxyformamido)-2-(3-(carboxymethyl)ureido)propanoic Acid as A Novel PSMA Targeting Scaffold for Prostate Cancer Imaging.

M. Pomper, Jingming Zhang, I. Minn, 2020, Journal of medicinal chemistry.